Sign-up for our newsletter
MAIN
Event Calendar
Awardee Reports
ABOUT DIACOMP
Citing DiaComp
Contact
Committees
Institutions
Awardee Reports
Publications
Bioinformatics
RESOURCES
Protocols & Methods
Reagents & Resources
Mouse Diet
Breeding Schemes
Validation Criteria
IMPC / KOMP Data
Publications
Bioinformatics
CONTACT
PARTICIPANT AREA
Login
▹
Publications
▹
Home
Publication
Collagen Stiffness and Architecture Regulate Fibrotic Gene Expression in
Engineered Adipose Tissue.
Authors
Di Caprio N, Bellas E
Submitted By
Submitted Externally on 7/20/2020
Status
Published
Journal
Advanced biosystems
Year
2020
Date Published
6/1/2020
Volume : Pages
4 : e1900286
PubMed Reference
32529801
Abstract
Adipose tissue (AT) has a dynamic extracellular matrix (ECM) surrounding
adipocytes that allows for remodeling during metabolic fluctuations. During the
progression of obesity, AT has increased ECM deposition, stiffening, and
remodeling, resulting in a pro-fibrotic dysfunctional state. Here, the
incorporation of ethylene glycol-bis-succinic acid N-hydroxysuccinimide ester
(PEGDS) allows for control over 3D collagen hydrogel stiffness and architecture
to investigate its influence on adipocyte metabolic and fibrotic function. Upon
stiffening and altering ECM architecture, adipocytes did not alter their
expression of key adipokines, leptin, and adiponectin. However, they do increase
actin cytoskeletal fiber formation, pro-fibrotic gene expression, ECM
deposition, and remodeling within a stiffer, 3D collagen hydrogel. For example,
COL6A3 gene expression is upregulated approximately twofold, resulting in
increased deposition of pericellular collagen VI alpha 3 surrounding adipocytes.
Furthermore, inhibition of actin contractility results in a reversal of
pro-fibrotic gene expression and ECM deposition, indicating that adipocytes are
mediating mechanical cues through actin cytoskeletal networks. This study
demonstrates that ECM stiffness and architecture plays a critical regulatory
role in adipocyte fibrotic function and contributes to the overall pro-fibrotic
dysfunctional state of AT during the progression of obesity and AT fibrosis.
Complications
All Complications
Bioinformatics
Bone
Cardiomyopathy
Cardiovascular
Gastro-Intestinal (GI)
Nephropathy
Neuropathy & Neurocognition
Pediatric Endocrinology
Retinopathy
Uropathy
Wound Healing
Welcome to the DiaComp Login / Account Request Page.
Email Address:
Password:
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
click here.
ERROR!
There was a problem with the page:
User Info
User Confirm
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!